Company Filing History:
Years Active: 1989-1993
Title: Sagrario Mochales: Innovator in Immunosuppressant Research
Introduction
Sagrario Mochales is a prominent inventor based in Madrid, Spain. She has made significant contributions to the field of immunosuppressants, with a total of three patents to her name. Her work focuses on developing new microorganisms and fermentation processes that have the potential to revolutionize organ transplant procedures.
Latest Patents
One of her latest patents involves a new microorganism, Actinoplanacete sp. (Merck Culture Collection MA 6559) ATCC No. 53771. This microorganism acts as a demethylating agent and is capable of producing novel immunosuppressants, including 'demethomycin' (L-682,993) and 'demethimmunomycin' (L-683,742). These macrolide immunosuppressants are particularly useful in preventing human host rejection of foreign organ transplants, such as bone marrow and heart transplants. Additionally, she has worked on the controlled aerobic fermentation of the fungal organism Fusarium lateritium var. longum, which produces xanthomegnin, a compound known for its potent antiparasitic, anthelminthic, and insecticidal activity.
Career Highlights
Sagrario Mochales is currently employed at Merck & Company, Inc., where she continues to advance her research in the field of immunology and microbiology. Her innovative approaches have garnered attention and respect within the scientific community.
Collaborations
Throughout her career, Sagrario has collaborated with notable colleagues, including Robert P. Borris and Richard W. Burg. These partnerships have contributed to the success of her research and the development of her patents.
Conclusion
Sagrario Mochales is a trailblazer in the field of immunosuppressant research, with her innovative work paving the way for advancements in organ transplantation. Her contributions are vital to improving patient outcomes and enhancing the efficacy of transplant procedures.